Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer and has a poor prognosis compared to ER-positive subtype and HER2-positive subtype of breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.